1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy.

Autor:	Russano, M.1 (AUTHOR), Cantini, L.2 (AUTHOR), B, A.P.3 (AUTHOR), George, R.3 (AUTHOR), Nunes, P.2 (AUTHOR), Tolba, K.2 (AUTHOR), Dutra, C.2 (AUTHOR), Chico, I.2 (AUTHOR), Cortellini, A.1 (AUTHOR), Pecci, F.4 (AUTHOR), Alessi, J.V.5 (AUTHOR), Ricciuti, B.4 (AUTHOR), Ramkissoon, S.6 (AUTHOR), Aerts, J.G.7 (AUTHOR), Agrawal, S.3 (AUTHOR), Saini, K.S.2 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 2, Vol. 35, pS854-S854. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu